Federica Brugnoli
Ferrara, 44121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Urinary Exosomal microRNAs as a Novel Approach to Study People with Multiple Sclerosis and Severe Gait Disability: A Preliminary Observation.
Journal: Non-coding RNA
Published: February 06, 2026
Skin Application of Inflammasome Inhibitor MCC950 Prevents Psoriasis-like Cutaneous Manifestations and Associated Systemic Inflammation.
Journal: Inflammation
Published: November 14, 2025
MicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker.
Journal: World journal of diabetes
Published: May 29, 2025
Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells.
Journal: Tissue engineering and regenerative medicine
Published: May 12, 2025
Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the K+ voltage-dependent Kv2.1 channel.
Journal: Journal of physiology and biochemistry
Published: May 03, 2025
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites.
Journal: International journal of molecular sciences
Published: December 15, 2024
Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling.
Journal: Cells
Published: March 29, 2024
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype.
Journal: International journal of molecular sciences
Published: June 16, 2023
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO.
Journal: Antioxidants (Basel, Switzerland)
Published: December 30, 2022
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines.
Journal: The FEBS journal
Published: December 08, 2022
Last Updated: 09/26/2026